Merck: Navigating Patent Cliff and Growth Prospects
Merck faces the challenge of expiring patents while pushing a robust pipeline and disciplined capital moves. This gui...
Need money fast? Explore the best ways to get quick funds and solve your financial challenges effectively. Get started today!
20,010 articlesMerck faces the challenge of expiring patents while pushing a robust pipeline and disciplined capital moves. This gui...
A new wave of weight-loss therapies aims to beat current GLP-1 drugs by reducing side effects and daily dosing. Inves...
A single trading day sent the 2x MU ETF tumbling as Micron shares fell and rates climbed, illustrating the double-edg...
A fresh government outlook puts social security's insolvency date at the end of 2032, prompting talks of payroll tax ...
A 3.9% COLA could meaningfully lift a typical Social Security check in 2027. This guide breaks down what that means i...
SpaceX IPO buzz is rising, but the hype can mislead older investors. A new market briefing outlines the risks and pra...
A new income-focused ETF challenger has pushed past JEPI by roughly 42 percentage points since its October 2023 debut...
SpaceX just joined the public markets with a thunderous first day. A 19% gain sparked headlines, but smart investors ...
Memory and storage stocks rise as a tentative Iran truce lifts risk appetite. Micron Technology and Western Digital l...
Investors are buzzing after Simulations Plus announced a cash buyout at $18.50 per share. This deep-dive explains why...
A high-profile insider sale sparked questions about Bandwidth and its stock. This in-depth guide explains what bandwi...
A daring forecast from Goldman Sachs imagines SpaceX turning into a multi-hundred-billion-dollar revenue machine by 2...